1163443001: Mosapride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Substance with serotonin receptor agonist mechanism of action (substance)\Serotonin 5-HT4 receptor agonist\Mosapride

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Gastrointestinal agent (substance)\Mosapride

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Mosapride

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Mosapride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4596877018 Mosapride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4596878011 Mosapride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Mosapride	Is a	Gastrointestinal agent (substance)	true	Inferred relationship	Some
Mosapride	Is a	Substance with benzamide structure	true	Inferred relationship	Some
Mosapride	Is a	Serotonin 5-HT4 receptor agonist	true	Inferred relationship	Some
Mosapride	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Serotonin 5-hydroxytryptamine-4 receptor agonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Mosapride citrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Mosapride	Inferred relationship	Some
Mosapride-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mosapride	Inferred relationship	Some	1
Product containing mosapride (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mosapride	Inferred relationship	Some	1
Product containing only mosapride (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mosapride	Inferred relationship	Some	1
Product containing only mosapride in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mosapride	Inferred relationship	Some	1

This concept is not in any reference sets